Melanie Mahtani
Nessuna posizione attualmente
Profilo
Melanie Mahtani served as Interim CEO at Telome Health, Inc. from 2010 to 2011.
She was Vice President of Business Development at GenoSpectra, Inc. She was also Chief Geneticist at Cellscape Corp.
from 2012 to 2014.
From 2016 to 2017, she served as Chief Scientific Advisor at MaRS Discovery District (Venture Capital).
Dr. Mahtani holds an undergraduate degree from Brown University and a doctorate from Stanford University.
Precedenti posizioni note di Melanie Mahtani
Società | Posizione | Fine |
---|---|---|
AEENA Dx, Inc.
AEENA Dx, Inc. Medical SpecialtiesHealth Technology AEENA Dx, Inc. is a company based in Mountain View, CA. The company's description is "nowdx". Robert K. Weigle has been the CEO of the company since 2020. | Direttore operativo | 01/06/2021 |
MaRS Discovery District (Venture Capital)
MaRS Discovery District (Venture Capital) Investment ManagersFinance MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada. | Consulente / Consigliere | 01/01/2017 |
Cellscape Corp.
Cellscape Corp. Data Processing ServicesTechnology Services Cellscape Corp. provides data analytics services. The company is based in Mountain View, CA. The company was founded by Bhairavi Parikh, Karen Ruth Drexler, James Stone. | Corporate Officer/Principal | 01/06/2014 |
Telome Health, Inc. | Amministratore Delegato | 01/01/2011 |
GenoSpectra, Inc.
GenoSpectra, Inc. BiotechnologyHealth Technology Genospectra, Inc. was a life science company developing technologies and products for Parallel Quantitative Biology (PQB). Genospectra's PQB initiative was focused on creating novel cell-based assays and tools that enable multiplex measurements of molecular events, such as intracellular pathway analysis, in a quantitative and scalable manner. Genospectra's first product line, the QuantiGene Reagent System was launched in 2003, and was powered by the FDA approved and proprietary branched DNA technology for gene expression analysis in cell-based assays. Genospectra was headquartered in Fremont, CA. | Corporate Officer/Principal | - |
Formazione di Melanie Mahtani
Brown University | Undergraduate Degree |
Stanford University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 5 |
---|---|
GenoSpectra, Inc.
GenoSpectra, Inc. BiotechnologyHealth Technology Genospectra, Inc. was a life science company developing technologies and products for Parallel Quantitative Biology (PQB). Genospectra's PQB initiative was focused on creating novel cell-based assays and tools that enable multiplex measurements of molecular events, such as intracellular pathway analysis, in a quantitative and scalable manner. Genospectra's first product line, the QuantiGene Reagent System was launched in 2003, and was powered by the FDA approved and proprietary branched DNA technology for gene expression analysis in cell-based assays. Genospectra was headquartered in Fremont, CA. | Health Technology |
AEENA Dx, Inc.
AEENA Dx, Inc. Medical SpecialtiesHealth Technology AEENA Dx, Inc. is a company based in Mountain View, CA. The company's description is "nowdx". Robert K. Weigle has been the CEO of the company since 2020. | Health Technology |
Cellscape Corp.
Cellscape Corp. Data Processing ServicesTechnology Services Cellscape Corp. provides data analytics services. The company is based in Mountain View, CA. The company was founded by Bhairavi Parikh, Karen Ruth Drexler, James Stone. | Technology Services |
MaRS Discovery District (Venture Capital)
MaRS Discovery District (Venture Capital) Investment ManagersFinance MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada. | Finance |
Telome Health, Inc. |
- Borsa valori
- Insiders
- Melanie Mahtani